Revance Therapeutics - 10 Year Stock Price History | RVNC

The latest closing stock price for Revance Therapeutics as of November 20, 2024 is 3.80.

  • An investor who bought $1,000 worth of Revance Therapeutics stock at the IPO in 2014 would have $-858 today, roughly -1 times their original investment - a -16.28% compound annual growth rate over 11 years.
  • The all-time high Revance Therapeutics stock closing price was 40.78 on November 11, 2015.
  • The Revance Therapeutics 52-week high stock price is 9.74, which is 156.3% above the current share price.
  • The Revance Therapeutics 52-week low stock price is 2.30, which is 39.5% below the current share price.
  • The average Revance Therapeutics stock price for the last 52 weeks is 5.10.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Revance Therapeutics - 10 Year Stock Price History | RVNC

  • An investor who bought $1,000 worth of Revance Therapeutics stock at the IPO in 2014 would have $-858 today, roughly -1 times their original investment - a -16.28% compound annual growth rate over 11 years.
  • The all-time high Revance Therapeutics stock closing price was 40.78 on November 11, 2015.
  • The Revance Therapeutics 52-week high stock price is 9.74, which is 156.3% above the current share price.
  • The Revance Therapeutics 52-week low stock price is 2.30, which is 39.5% below the current share price.
  • The average Revance Therapeutics stock price for the last 52 weeks is 5.10.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.